Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaron

Showing results (21-30 of 5,390) with videos related to

Pageof 539
Sort By:
Nursing Management|May 7, 2004
Nurses get IT rightR Yaron
Medical Hypotheses|July 5, 2011
Gradual cessation of proton pump inhibitor (PPI) treatment may prevent rebound acid secretion, measured by the alkaline tide method, in dyspepsia and reflux patientsYaron Niv
European Journal of Gastroenterology & Hepatology|September 15, 2015
Estrogen receptor β expression and colorectal cancer: a systematic review and meta-analysisYaron Niv
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 19, 2015
Comment on "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial" by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226-32]Yaron Rotman
Katedrah Be-Toldot Erets-Yisra'El Ve-Yishuvah|November 29, 2007
[The British hospital in Safed]Yaron Perry
Journal of Autoimmunity|December 22, 2009
Hepatitis C and interferon induced thyroiditisYaron Tomer
Cardiology|July 3, 2018
Proton Pump Inhibitors and Dual Antiplatelet Therapy: Is the Story Over?Yaron Arbel
Digestive Diseases (Basel, Switzerland)|July 5, 2008
Ethical aspects of capsule endoscopyYaron Niv
Annual Review of Physical Chemistry|November 13, 2008
Quantum coherent control for nonlinear spectroscopy and microscopyYaron Silberberg
The Science of the Total Environment|July 8, 2020
Response to the commentary by Pisoni E. and Van Dingenen R. on 'Assessing nitrogen dioxide (NO<sub>2</sub>) levels as a contributing factor to coronavirus (COVID-19) fatality'Yaron Ogen
Pageof 539

Showing results (21-30 of 5,390) with videos related to

Sort By:
Pageof 539
Nursing Management|May 7, 2004
Nurses get IT rightR Yaron
Medical Hypotheses|July 5, 2011
Gradual cessation of proton pump inhibitor (PPI) treatment may prevent rebound acid secretion, measured by the alkaline tide method, in dyspepsia and reflux patientsYaron Niv
European Journal of Gastroenterology & Hepatology|September 15, 2015
Estrogen receptor β expression and colorectal cancer: a systematic review and meta-analysisYaron Niv
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 19, 2015
Comment on "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial" by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226-32]Yaron Rotman
Katedrah Be-Toldot Erets-Yisra'El Ve-Yishuvah|November 29, 2007
[The British hospital in Safed]Yaron Perry
Journal of Autoimmunity|December 22, 2009
Hepatitis C and interferon induced thyroiditisYaron Tomer
Cardiology|July 3, 2018
Proton Pump Inhibitors and Dual Antiplatelet Therapy: Is the Story Over?Yaron Arbel
Digestive Diseases (Basel, Switzerland)|July 5, 2008
Ethical aspects of capsule endoscopyYaron Niv
Annual Review of Physical Chemistry|November 13, 2008
Quantum coherent control for nonlinear spectroscopy and microscopyYaron Silberberg
The Science of the Total Environment|July 8, 2020
Response to the commentary by Pisoni E. and Van Dingenen R. on 'Assessing nitrogen dioxide (NO<sub>2</sub>) levels as a contributing factor to coronavirus (COVID-19) fatality'Yaron Ogen
Pageof 539